JHS — JHS Svendgaard Laboratories Cashflow Statement
0.000.00%
- IN₹788.40m
- IN₹770.81m
- IN₹1.02bn
Annual cashflow statement for JHS Svendgaard Laboratories, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 1.03 | -218 | -34.3 | -125 | -22.9 |
| Depreciation | |||||
| Non-Cash Items | -68.7 | 189 | -6.17 | 39.2 | -19.5 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -94.2 | 144 | -109 | -45.4 | -59.1 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -91.4 | 189 | -85.8 | -51.8 | -26.6 |
| Capital Expenditures | -67.4 | -11 | -315 | -105 | -128 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 20.4 | 73.3 | 98 | -97.2 | 11.2 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -47 | 62.3 | -217 | -203 | -117 |
| Financing Cash Flow Items | -10.1 | -7.97 | -4.12 | -2.26 | -8 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -16.7 | 81 | 21.7 | 231 | 113 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -155 | 332 | -281 | -23.6 | -29.9 |